WallStreetZenWallStreetZen

NASDAQ: CHRS
Coherus Oncology Inc Stock Ownership - Who owns Coherus Oncology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Coherus Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dennis M. LanfearPresident CEO2026-01-2011,839$1.55
$18.35kSell
Bryan J. McMichaelChief Financial Officer2026-01-201,715$1.55
$2.66kSell
Mats WahlstromDirector2025-05-2399,988$0.74
$73.89kSell

1 of 1

CHRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CHRS insiders and whales buy or sell their stock.

CHRS Shareholders

What type of owners hold Coherus Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc8.74%10,562,709$17.22MInstitution
Vanguard Group Inc8.30%10,028,893$16.35MInstitution
Vsciences Investments Pte Ltd6.11%7,381,116$12.03MInsider
Lilly Co Eli2.52%3,042,019$4.96MInsider
Kohlberg Kravis Roberts Co LP2.51%3,036,076$4.95MInstitution
Dennis M. Lanfear2.42%2,926,612$4.77MInsider
Daiichi Sankyo Company Ltd2.37%2,867,426$4.67MInsider
Geode Capital Management LLC2.27%2,745,246$4.47MInstitution
Tang Capital Management LLC2.25%2,724,509$4.44MInstitution
Kkr Biosimilar LP2.07%2,499,499$4.07MInsider

1 of 3

CHRS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CHRS42.29%17.72%Net SellingNet Selling
VYGR53.20%46.80%Net SellingNet Selling
NTHI10.18%89.82%Net BuyingNet Buying
GALT13.13%86.87%Net SellingNet Selling
QSI31.19%47.53%Net SellingNet Selling
View Top Biotech Stocks

Coherus Oncology Stock Ownership FAQ

Who owns Coherus Oncology?

Coherus Oncology (NASDAQ: CHRS) is owned by 42.29% institutional shareholders, 17.72% Coherus Oncology insiders, and 39.99% retail investors. Vsciences Investments Pte Ltd is the largest individual Coherus Oncology shareholder, owning 7.38M shares representing 6.11% of the company. Vsciences Investments Pte Ltd's Coherus Oncology shares are currently valued at $12.03M.

If you're new to stock investing, here's how to buy Coherus Oncology stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.